CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Activity

23 hedge funds and large institutions have $1.94M invested in CASI Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
4
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

1
VA
1
VR Adviser
New York
$614K
2
UBS Group
2
UBS Group
Switzerland
$62.3K
3
ACM
3
ADAR1 Capital Management
Texas
$45.3K
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$38K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$224K

Top Sellers

1
HCM
1
Howland Capital Management
Massachusetts
$82.9K
2
Wells Fargo
2
Wells Fargo
California
$2.78K
3
WSCM
3
Wellington Shields Capital Management
New York
$491K
4
CFM
4
Catalyst Funds Management
Australia
$44
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
IA
26
IFP Advisors
Florida
– – -40 Closed
MFG
27
Mendota Financial Group
Wisconsin
– – -20 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
1
2